Switzerland is non-EU but closely EU-aligned in its regulatory framework. Swissmedic regulates medicines (closely mirroring EU-GMP via MRA); fedpol handles narcotic licensing. Medical cannabis operates via a dual pathway: full Swissmedic marketing authorisation or cantonal exceptional authorizations (Ausnahmebewilligungen). All 26 cantons have their own exceptional authorization procedures, creating complexity for national market entry.
Ask the Expert about Switzerland